Literature DB >> 2170830

Animal cytomegaloviruses.

J Staczek1.   

Abstract

Cytomegaloviruses are agents that infect a variety of animals. Human cytomegalovirus is associated with infections that may be inapparent or may result in severe body malformation. More recently, human cytomegalovirus infections have been recognized as causing severe complications in immunosuppressed individuals. In other animals, cytomegaloviruses are often associated with infections having relatively mild sequelae. Many of these sequelae parallel symptoms associated with human cytomegalovirus infections. Recent advances in biotechnology have permitted the study of many of the animal cytomegaloviruses in vitro. Consequently, animal cytomegaloviruses can be used as model systems for studying the pathogenesis, immunobiology, and molecular biology of cytomegalovirus-host and cytomegalovirus-cell interactions.

Entities:  

Mesh:

Year:  1990        PMID: 2170830      PMCID: PMC372776          DOI: 10.1128/mr.54.3.247-265.1990

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN: 0146-0749


  322 in total

1.  Mechanism of exudation through intact alveolar epithelial cells in the lungs of cytomegalovirus-infected mice.

Authors:  A R Brody; P C Kelleher; J E Craighead
Journal:  Lab Invest       Date:  1978-09       Impact factor: 5.662

2.  Monocyte migration across pulmonary membranes in mice infected with cytomegalovirus.

Authors:  G F Murphy; A R Brody; J E Craighead
Journal:  Exp Mol Pathol       Date:  1975-02       Impact factor: 3.362

3.  The isolation and partial characterization of a herpesvirus from a case of bovine metritis.

Authors:  J B Parks; J W Kendrick
Journal:  Arch Gesamte Virusforsch       Date:  1973

4.  Characterization of a cytomegalo-like virus isolated from spontaneously degenerated equine kidney cell culture.

Authors:  G D Hsiung; H R Fischman; C K Fong; R H Green
Journal:  Proc Soc Exp Biol Med       Date:  1969-01

5.  Transcription in mouse embryo cells permissively infected by murine cytomegalovirus.

Authors:  J R Marks; J A Mercer; D H Spector
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

6.  Genetic analysis of the susceptibility of mouse cytomegalovirus to acyclovir.

Authors:  G R Sandford; J R Wingard; J W Simons; S P Staal; R Saral; W H Burns
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

7.  Induction of thymidine kinase activity by viruses with group B DNA genomes: bovine cytomegalovirus (bovine herpesvirus 4).

Authors:  S Kit; M Kit; H Ichimura; R Crandell; S McConnell
Journal:  Virus Res       Date:  1986-02       Impact factor: 3.303

8.  Murine cytomegalovirus-induced macrophage dysfunction.

Authors:  E L Pesanti; J D Shanley
Journal:  J Leukoc Biol       Date:  1984-08       Impact factor: 4.962

9.  Physical mapping of a genome of equine herpesvirus 2 (equine cytomegalovirus).

Authors:  G F Browning; M J Studdert
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  Lymphadenopathy during cytomegalovirus-induced mononucleosis in guinea pigs.

Authors:  H L Lucia; B P Griffith; G D Hsiung
Journal:  Arch Pathol Lab Med       Date:  1985-11       Impact factor: 5.534

View more
  17 in total

1.  Characterization of a new disease syndrome associated with porcine circovirus type 2 in previously vaccinated herds.

Authors:  Ada G Cino-Ozuna; Steven Henry; Richard Hesse; Jerome C Nietfeld; Jianfa Bai; H Morgan Scott; Raymond R R Rowland
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

2.  Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism.

Authors:  V J Cavanaugh; R M Stenberg; T L Staley; H W Virgin; M R MacDonald; S Paetzold; H E Farrell; W D Rawlinson; A E Campbell
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.

Authors:  L D Cranmer; C L Clark; C S Morello; H E Farrell; W D Rawlinson; D H Spector
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  DNA immunization confers protection against murine cytomegalovirus infection.

Authors:  J C González Armas; C S Morello; L D Cranmer; D H Spector
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette.

Authors:  J Vieira; H E Farrell; W D Rawlinson; E S Mocarski
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice.

Authors:  Scott J Schachtele; Manohar B Mutnal; Mark R Schleiss; James R Lokensgard
Journal:  J Neurovirol       Date:  2011-03-18       Impact factor: 2.643

7.  Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).

Authors:  Alistair McGregor; Fenyong Liu; Mark R Schleiss
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice.

Authors:  T W Booth; A A Scalzo; C Carrello; P A Lyons; H E Farrell; G R Singleton; G R Shellam
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis.

Authors:  Angie Rupp; Francesc Galban-Horcajo; Ezio Bianchi; Maurizio Dondi; Jacques Penderis; Joanna Cappell; Karl Burgess; Kaspar Matiasek; Rhona McGonigal; Hugh J Willison
Journal:  J Peripher Nerv Syst       Date:  2013-03       Impact factor: 3.494

10.  Human cytomegalovirus immediate-early-gene expression disrupts embryogenesis in transgenic Drosophila.

Authors:  Racheli Steinberg; Yonat Shemer-Avni; Noa Adler; Shira Neuman-Silberberg
Journal:  Transgenic Res       Date:  2007-10-03       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.